Strength training with blood flow restriction diminishes myostatin gene expression

Medicine and Science in Sports and Exercise

Volumn 44, Issue 3, 2012, Pages 406-412

  Laurentino, Gilberto Candido ^a   Ugrinowitsch, Carlos ^a   Roschel, Hamilton ^a   Aoki, Marcelo Saldanha ^a   Soares, Antonio Garcia ^a   Neves Jr , Manoel ^a   Aihara, Andréyui ^b   Da Rocha Correa Fernandes, Artur ^b   Tricoli, Valmor ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

HYPOXIA; MUSCLE BIOPSY; RESISTANCE TRAINING; SKELETAL MUSCLE HYPERTROPHY; VASCULAR OCCLUSION

Indexed keywords

ACTIVIN RECEPTOR 2; FOLLISTATIN; MESSENGER RNA; MSTN PROTEIN, HUMAN; MYOSTATIN; PROTEIN; SMAD7 PROTEIN; SMAD7 PROTEIN, HUMAN; WFIKKNRP PROTEIN, HUMAN;

ADAPTATION; ADULT; ARTICLE; BIOPSY; BLOOD FLOW; GENE EXPRESSION; GENETICS; HUMAN; KNEE; LIGATION; MALE; METHODOLOGY; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; RESISTANCE TRAINING; SKELETAL MUSCLE; VASCULARIZATION;

ACTIVIN RECEPTORS, TYPE II; ADAPTATION, PHYSIOLOGICAL; BIOPSY; CONSTRICTION; FOLLISTATIN; GENE EXPRESSION; HUMANS; KNEE JOINT; MALE; MUSCLE, SKELETAL; MYOSTATIN; PROTEINS; REAL-TIME POLYMERASE CHAIN REACTION; REGIONAL BLOOD FLOW; RESISTANCE TRAINING; RNA, MESSENGER; SMAD7 PROTEIN; YOUNG ADULT;

EID: 84857630081     PISSN: 01959131     EISSN: 15300315     Source Type: Journal    
DOI: 10.1249/MSS.0b013e318233b4bc     Document Type: Article

References (33)

1. Aoki MS, Soares AG, Miyabara EH, Baptista IL, Moriscot AS. Expression of genes related to myostatin signaling during rat skeletal muscle longitudinal growth. Muscle Nerve. 2009;40(6): 992-9.
2. Bodine SC, Stitt TN, Gonzalez M, et al. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol. 2001;3(11): 1014-9. (Pubitemid 34428747)
3. Bolster DR, Kimball SR, Jefferson LS. Translational control mechanisms modulate skeletal muscle gene expression during hypertrophy. Exerc Sport Sci Rev. 2003;31(3):111-6. (Pubitemid 36886022)
4. Brown LE, Weir JP. ASEP procedures recommendation I: accurate assessment of muscular strength and power. J Exerc Physiol Online. 2001;4(3):1-21. (Pubitemid 38888644)
5. Bustin SA, Benes V, Garson JA, et al. The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem. 2009;55(4):611-22.
6. Campos GE, Luecke TJ, Wendeln HK, et al. Muscular adaptations in response to three different resistance-training regimens: specificity of repetition maximum training zones. Eur J Appl Physiol. 2002;88(1-2):50-60. (Pubitemid 40826308)
7. Coffey VG, Shield A, Canny BJ, Carey KA, Cameron-Smith D, Hawley JA. Interaction of contractile activity and training history on mRNA abundance in skeletal muscle from trained athletes. Am J Physiol Endocrinol Metab. 2006;290(5):E849-55.
8. Crenshaw AG, Hargens AR, Gershuni DH, Rydevik B. Wide tourniquet cuffs more effective at lower inflation pressures. Acta Orthop Scand. 1988;59(4):447-51.
9. Drummond MJ, Fujita S, Abe T, Dreyer HC, Volpi E, Rasmussen BB. Human muscle gene expression following resistance exercise and blood flow restriction. Med Sci Sports Exerc. 2008;40(4):691-8. (Pubitemid 351416844)
10. Forbes D, Jackman M, Bishop A, Thomas M, Kambadur R, Sharma M. Myostatin auto-regulates its expression by feedback loop through Smad7 dependent mechanism. J Cell Physiol. 2006; 206(1):264-72. (Pubitemid 41740740)
11. Glass DJ. Skeletal muscle hypertrophy and atrophy signaling pathways. Int J Biochem Cell Biol. 2005;37(10):1974-84. (Pubitemid 41206815)
12. Hayashi H, Abdollah S, Qiu Y, et al. The MAD-related protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling. Cell. 1997;89(7):1165-73. (Pubitemid 127678749)
13. Hill JJ, Qiu Y, Hewick RM, Wolfman NM. Regulation of myostatin in vivo by growth and differentiation factor-associated serum protein-1: a novel protein with protease inhibitor and follistatin domains. Mol Endocrinol. 2003;17(6):1144-54. (Pubitemid 36683721)
14. Hulmi JJ, Ahtiainen JP, Kaasalainen T, et al. Postexercise myostatin and activin IIb mRNA levels: effects of strength training. Med Sci Sports Exerc. 2007;39(2):289-97. (Pubitemid 46204296)
15. Jespersen JG, Nedergaard A, Andersen LL, Schjerling P, Andersen JL. Myostatin expression during human muscle hypertrophy and subsequent atrophy: increased myostatin with detraining. Scand J Med Sci Sports. 2011;21(2):215-23.
16. Karabulut M, Abe T, Sato Y, Bemben MG. The effects of lowintensity resistance training with vascular restriction on leg muscle strength in older men. Eur J Appl Physiol. 2010;108(1):147-55.
17. Kollias HD, Perry RL, Miyake T, Aziz A, McDermott JC. Smad7 promotes and enhances skeletal muscle differentiation. Mol Cell Biol. 2006;26(16):6248-60. (Pubitemid 44204541)
18. Kubo K, Komuro T, Ishiguro N, et al. Effects of low-load resistance training with vascular occlusion on the mechanical properties of muscle and tendon. J Appl Biomech. 2006;22(2):112-9.
19. Laurentino G, Ugrinowitsch C, Aihara AY, et al. Effects of strength training and vascular occlusion. Int J Sports Med. 2008; 29(8):664-7.
20. Lee SJ. Regulation of muscle mass by myostatin. Annu Rev Cell Dev Biol. 2004;20:61-86.
21. Lee SJ, McPherron AC. Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci U S A. 2001;98(16):9306-11. (Pubitemid 32743912)
22. Matsakas A, Patel K. Intracellular signalling pathways regulating the adaptation of skeletal muscle to exercise and nutritional changes. Histol Histopathol. 2009;24(2):209-22.
23. McPherron AC, Lee SJ. Double muscling in cattle due to mutations in the myostatin gene. Proc Natl Acad Sci U S A. 1997;94(23): 12457-61. (Pubitemid 27492550)
24. Patel K, Amthor H. The function of myostatin and strategies of myostatin blockade-new hope for therapies aimed at promoting growth of skeletal muscle. Neuromuscul Disord. 2005;15(2): 117-26. (Pubitemid 40202738)
25. Roth SM, Martel GF, Ferrell RE, Metter EJ, Hurley BF, Rogers MA. Myostatin gene expression is reduced in humans with heavy-resistance strength training: a brief communication. Exp Biol Med (Maywood). 2003;228(6):706-9. (Pubitemid 37163261)
26. Roth SM, Walsh S. Myostatin: a therapeutic target for skeletal muscle wasting. Curr Opin Clin Nutr Metab Care. 2004;7(3): 259-63. (Pubitemid 40340662)
27. Saremi A, Gharakhanloo R, Sharghi S, Gharaati MR, Larijani B, Omidfar K. Effects of oral creatine and resistance training on serum myostatin and GASP-1. Mol Cell Endocrinol. 2010;317(1-2): 25-30.
28. Schuelke M, Wagner KR, Stolz LE, et al. Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med. 2004;350(26):2682-8. (Pubitemid 38788003)
29. Takarada Y, Takazawa H, Sato Y, Takebayashi S, Tanaka Y, Ishii N. Effects of resistance exercise combined with moderate vascular occlusion on muscular function in humans. J Appl Physiol. 2000;88(6):2097-106. (Pubitemid 30453915)
30. Walker KS, Kambadur R, Sharma M, Smith HK. Resistance training alters plasma myostatin but not IGF-1 in healthy men. Med Sci Sports Exerc. 2004;36(5):787-93. (Pubitemid 38596382)
31. Willoughby DS. Effects of heavy resistance training on myostatin mRNA and protein expression. Med Sci Sports Exerc. 2004;36(4): 574-82. (Pubitemid 38452028)
32. Yang Y, Creer A, Jemiolo B, Trappe S. Time course of myogenic and metabolic gene expression in response to acute exercise in human skeletal muscle. J Appl Physiol. 2005;98(5):1745-52. (Pubitemid 40570785)
33. Yang Y, Jemiolo B, Trappe S. Proteolytic mRNA expression in response to acute resistance exercise in human single skeletal muscle fibers. J Appl Physiol. 2006;101(5):1442-50.